Quality assessment | Summary of findings | |||||||
---|---|---|---|---|---|---|---|---|
 |  |  |  |  | Number of patients | Effect | Quality of evidence | |
No of studies/Design | Limitations | Inconsistency | Indirectness | Imprecision | amoxicillin | benzyl penicillin | Odds ratio (95% CI)/P value | Â |
Outcome 1: Treatment failure based on clinical signs. Assessed at 48 hours [25]and 5 days [28] Importance: Critical | Â | |||||||
no serious limitations | no serious inconsistency | serious1 | no serious imprecision | 244/1882 (13.0%) | 248/1857 (13.4%) | 0.97 (0.80-1.17) | Moderate | |
Outcome 2: Time to resolution of signs of pneumonia Importance: Critical | Â | |||||||
1 RCT [27] | no serious limitations | no serious inconsistency | serious2 | no serious imprecision | 100 (1.3 days) †| 103 (1.3 days)†| P = 0.001 for equivalence | Moderate |
Outcome 3: Mortality Importance: Critical | Â | |||||||
No studies | - | - | - | - | - | - | - | - |
Outcome 4: Cost Importance: Important | Â | |||||||
No studies | - | - | - | - | - | - | - | - |
Overall quality of evidence: Moderate quality evidence suggests that the two treatments are equivalent for outcomes assessed | Â | |||||||
Benefits or desired effects | Safety of oral over injectable treatments, convenient dosing schedule (twice daily for amoxicillin versus four times a day for benzyl penicillin) | |||||||
Risks or undesired effects | None identified | |||||||
Values and preferences | Painless oral administration for amoxicillin preferable to injectable route required for benzyl penicillin/ampicillin, Mothers like injections; Mothers would not stay in hospital for oral medications; Staff would not feel they were giving a strong enough treatment for a severe disease | |||||||
Costs | Potential reduction in cost of resources required for injectable treatment including the option of out-patient management | |||||||
Feasibility | Both antibiotics widely available and in use |